{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "60000977",
    "licUnit": "1",
    "validDate": "2025-09-08 00:00:00.000",
    "issueDate": "2015-09-08 00:00:00.000",
    "oriIssueDate": null,
    "licKind": "04",
    "oldLicid": null,
    "certNo": "DHA06000097701",
    "prodNameC": "安挺樂 皮下注射劑162毫克",
    "prodNameE": "Actemra 162mg for SC Injection",
    "indicationsName": [
        "1.1\t類風濕性關節炎(RA)\r\nActemra®合併methotrexate (MTX)可用於治療成年人中度至重度類風濕性關節炎，曾使用一種或一種以上之DMARD藥物治療或腫瘤壞死因子拮抗劑(TNF antagonist)治療而反應不佳或無法耐受的病人。在這些病人中，若病人對MTX無法耐受或不適合繼續投與MTX，可給Actemra®單獨治療。當 Actemra ®與MTX合併使用時，經 X光量測，可減緩關節傷害惡化速度，此外，經 HAQ-DI 量表評估，可改善生理功能。\r\n\r\n1.2\t巨細胞動脈炎(GCA)\r\nActemra®適用於治療成人巨細胞動脈炎(GCA)。\r\n"
    ],
    "does": "227D",
    "packageUnit": [
        {
            "packageSpec": "",
            "packageUnit": "2U"
        },
        {
            "packageSpec": "100支以下",
            "packageUnit": "03"
        }
    ],
    "medMCode": "05",
    "maMedCode": "",
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "22EBEA7A-0244-4861-ACF4-F7D3D8FD27E3",
    "subCategory": [],
    "ingredientsDesc": [
        "Tocilizumab"
    ],
    "restraintItemsCode": [
        "02",
        "07",
        "67"
    ],
    "applicantName": "台灣中外製藥股份有限公司",
    "applicantAddr": "台北市松山區敦化北路260號3樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": "2020-09-08",
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "55BABBED-C6F3-4DF7-A89C-D4842498FE54",
            "factoryCode": "1",
            "factoryName": "UTSUNOMIYA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.",
            "factoryAddr": "16-3 KIYOHARA KOGYODANCHI, UTSUNOMIYA-CITY, TOCHIGI, JAPAN",
            "factoryCompanyAddr": null,
            "countryCode": "JP",
            "processCode": [
                {
                    "value": "2I",
                    "name": "原料藥及成品製造廠"
                }
            ],
            "processCodeStr": "2I;原料藥及成品製造廠",
            "factoryKind": "M",
            "factoryNo": "FJP0724000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "1CB7FC3A-41CF-4A39-AEAA-99A836C1D3BC",
            "factoryCode": "2",
            "factoryName": "BUSHU PHARMACEUTICALS LTD. MISATO FACTORY",
            "factoryAddr": "950 HIROKI OHAZA MISATO-MACHI KODAMA-GUN SAITAMA-KEN, JAPAN",
            "factoryCompanyAddr": "",
            "countryCode": "JP",
            "processCode": [
                {
                    "value": "1A",
                    "name": "二級包裝廠"
                }
            ],
            "processCodeStr": "1A;二級包裝廠",
            "factoryKind": "M",
            "factoryNo": "FJP0826000",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013002800",
            "ingredientsName": "Tocilizumab",
            "ingredientsDesc": "Tocilizumab",
            "concentDesc": "",
            "concent": "162.0000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L04AC07"
        }
    ],
    "licBaseId": "C00AC490-ECC2-43E6-8968-A9DDBA75677B"
}